We recently attended the GBA1 conference in Montreal, which brought together researchers, clinicians, biotech leaders, and patient advocates to discuss cutting-...
Continue reading
Myasthenia gravis (MG) is a chronic neuromuscular disorder (NMD) that is characterized by muscle fatigue and weakness. It is considered a rare disease, affectin...
Continue reading
Precision medicine has fundamentally changed how diseases are defined and how therapies are developed — shifting eligibility from clinical phenotype to molecula...
Continue reading
Biomarker testing is foundational to precision medicine. It determines eligibility for targeted therapies and immunotherapies, informs treatment selection, and ...
Continue reading
As the demand for personalized therapies continues to grow, trial designs must evolve to reflect the biological variability between patients. Traditional models...
Continue reading
News of a ‘CRISPR baby’ broke this week, almost seven years after the first CRISPR baby scandal unleashed a media frenzy and years of ethical debates. But this ...
Continue reading
Although long COVID cases have surged in recent years, the genetic factors that influence who develops the condition remain poorly understood. Traditional genom...
Continue reading
We’re proud to share that Sano Genetics plays a key role in the newly announced Lupus Nexus Foundational Analyses, a groundbreaking initiative led by the Lupus ...
Continue reading
.png)
In a recent episode of The Genetics Podcast, Patrick Short sits down with Dr. Euan Ashley, Chair of Medicine at Stanford University, author of The Genome Odysse...
Continue reading
In a recent episode of The Genetics Podcast, Patrick spoke with Kent Rogers, CEO of EveryONE Medicines, about the future of individualized medicines, especially...
Continue reading